Neuroscience

New treatment hope for amyotrophic lateral sclerosis

A previously unknown link between the immune system and the death of motor neurons in Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been discovered by scientists at the CHUM Research Centre ...

Neuroscience

Could heavier folks be at lower risk for ALS?

It's not often that anything good is associated with obesity. Yet heavy folks and those who bulk up as they age may have less risk for the deadly disease amyotrophic lateral sclerosis (ALS), a new study finds.

Diseases, Conditions, Syndromes

Mild obesity appears to improve survival in ALS patients

Patients with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, may be an exception to the rule that being overweight is a health hazard. In a retrospective study of over 400 ALS patients, Massachusetts ...

Neuroscience

NFL players face 4 times the odds of ALS

NFL players are four times more likely to die of Lou Gehrig's disease (ALS) than other people, new research finds, adding to known links between football-related head injuries and brain diseases, including Alzheimer's, Parkinson's ...

Neuroscience

Biologists identify promising drug for ALS treatment

A drug typically used to treat hepatitis could slow the progression of ALS, also known as Lou Gehrig's disease, according to new research by University of Alberta scientists.

Diseases, Conditions, Syndromes

Potential new drug target in Lou Gehrig's disease

Two proteins conspire to promote a lethal neurological disease, according to a study published online this week in the Journal of Experimental Medicine.

Medical research

Researchers discover how ALS spreads

A study led by University of British Columbia and Vancouver Coastal Health Research Institute researchers has revealed how the fatal neurodegenerative disease amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's ...

page 2 from 6